74852-89-4 Usage
Description
Hydrazine Carboxamide,N-4-[4(4-methoxyphenyl)-1-pipezinyl]phenyl, also known as 4-[4-(4-Methyloxy-phenyl)-piperazin-1-yl]-phenyl-hydrazinecarboxamide (CAS# 74852-89-4), is a complex organic compound with a unique chemical structure. It is characterized by its purple solid appearance and is primarily recognized for its utility in organic synthesis.
Uses
Used in Organic Synthesis:
Hydrazine Carboxamide,N-4-[4(4-methoxyphenyl)-1-pipezinyl]phenyl is used as a synthetic building block in the chemical industry for the creation of various complex organic molecules. Its unique structure allows it to be a valuable component in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Hydrazine Carboxamide,N-4-[4(4-methoxyphenyl)-1-pipezinyl]phenyl is used as an intermediate in the development of new drugs. Its specific chemical properties make it a promising candidate for the synthesis of novel therapeutic agents, potentially targeting a wide range of medical conditions.
Used in Research and Development:
Hydrazine Carboxamide,N-4-[4(4-methoxyphenyl)-1-pipezinyl]phenyl is also utilized in research and development settings, where it can be employed to study the properties and reactivity of similar hydrazine carboxamides. Understanding the behavior of these compounds can lead to the discovery of new applications and advancements in the field of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 74852-89-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,8,5 and 2 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 74852-89:
(7*7)+(6*4)+(5*8)+(4*5)+(3*2)+(2*8)+(1*9)=164
164 % 10 = 4
So 74852-89-4 is a valid CAS Registry Number.
74852-89-4Relevant articles and documents
SMALL MOLECULE INHIBITORS OF FIBROSIS
-
Paragraph 00466, (2016/06/28)
Described herein are compounds and compositions for the treatment of a fibrotic disease.
ITRACONAZOLE ANALOGUES AND METHODS OF USE THEREOF
-
Page/Page column 0072, (2015/09/22)
Disclosed herein are analogues of itraconazole that are both angiogenesis and hedgehog signaling pathway inhibitors. The compounds are expected to be useful in the treatment of cancer, particularly cancers that are dependent upon the hedgehog signaling pathway such as basal cell carcinoma and medulloblastoma.
Substituted azolone derivatives
-
, (2008/06/13)
The use for the manufacture of a medicament for treating Helicobacter-related diseases of a compound of formula STR1 a pharmaceutically acceptable acid addition salt or a stereochemically isomeric form thereof, wherein X and Y each independently are CH or N; R1, R2 and R3 each independently are hydrogen or C1-4 alkyl; R4 and R5 each independently are hydrogen, halo, C1-4 alkyl, C1-4 alkyloxy, hydroxy, trifluoromethyl, trifluoromethyloxy or difluoromethyloxy; Z is C=O or CHOH; and Ar is phenyl optionally substituted with up to three substituents selected from hydroxy, C1-4 alkyl, C1-4 alkyloxy, halo, trifluoromethyl, triC1-4 alkylsilyloxy, nitro, amino and cyano or pyridinyl substituted with hydroxy or C1-4 alkyloxy; and --A-- is a radical of formula STR2